6533b862fe1ef96bd12c774b
RESEARCH PRODUCT
Antibiotic Coating of the Artificial Urinary Sphincter (AMS 800): Is it Worthwhile?
Tanja HüschJesco PfitzenmaierUlrich GreinWilhelm HübnerFrauke ThomsenAchim RoseRoberto OlianasRalf AndingKurt UlmFabian QueissertCarola WotzkaAlice ObajeDominik KronlachnerJosef SchweigerJoanne Nyarangi-dixTorben HofmannA. KretschmerM. KuroschRicarda M. BauerRoland HombergTobias PottekCarsten M. NaumannAxel HaferkampAlexander Friedlsubject
Malemedicine.medical_specialtyProsthesis-Related InfectionsMultivariate analysismedicine.drug_classUrologyAntibiotics030232 urology & nephrologyLong Term Adverse EffectsProsthesis DesignLogistic regressionRisk AssessmentGastroenterologyCohort StudiesArtificial urinary sphincter03 medical and health sciences0302 clinical medicineCoated Materials BiocompatibleRisk FactorsInternal medicineOutcome Assessment Health CaremedicineHumansAgedUnivariate analysisbusiness.industrySignificant differenceMiddle AgedAnti-Bacterial AgentsSurgeryUrinary Incontinence030220 oncology & carcinogenesisUrinary Tract InfectionsCohortUrinary Sphincter ArtificialFemalebusinessCohort studydescription
Objective To investigate the impact of the antibiotic coating InhibiZone on the infection and explantation rates of the AMS 800 in comparison to the AMS 800 without InhibiZone. Materials and Methods We retrospectively identified 305 patients with an AMS 800 in a multicenter cohort study. Patients were subsequently divided into InhibiZone and without InhibiZone-coated groups. Infection and explantation rates were analyzed by univariate and consecutively by multivariate logistic regression adjusted to variable risk factors. The infection-free interval was estimated by Kaplan-Meier plot and compared by the log-rank test. A P value below .05 was considered statistically significant. Results We identified 47 patients with InhibiZone and 258 without InhibiZone coating. In univariate analysis, we could not identify a significant difference in infection (P = .932) or explantation (P = .715) rates between the groups. In multivariate analysis, impaired wound healing (P = .008) and urethral erosion (P < .001) were independent predictors for infection. The InhibiZone coating neither demonstrated significant influence on the infection rate (P = .534) nor on the explantation rate (P = .214). There was no significant difference in estimated infection-free survival between the groups (P = .265). Conclusion The antibiotic coating of the AMS 800 had no significant impact on infection or explantation rates in our cohort.
year | journal | country | edition | language |
---|---|---|---|---|
2016-10-16 | Urology |